Andy Murray, this week competing for the final ATP Masters Series event of the year -- the BNP Paribas Masters in Bercy -- gave his thoughts on the current state of drug testing in tennis. Journos in France have it on their mind, obviously, now that one of their country's most prestigious sporting events, the Tour de France, has been left with a gaping hole after Lance Armstrong was stripped of his seven titles because of doping.
While tennis' drug testing schedule is comprehensive, Murray sees possible improvement in the off-season check-ups. "The out-of-competition stuff could probably get better," he said. "When we’re in December, when people are training and setting their bases, it would be good to do more around that time."
To learn more about doping in tennis check out our Q&A with Richard Ings, the former head of the ATP Anti-Doping Program and CEO of the Australian Sports Anti-Doping Authority.
Draw: Murray will play his opening round match on Wednesday against the winner of wildcard Mathieu and Baptista-Agut. See our thoughts on how the men will fare this week.
(File Photo: Andy Murray at the 2012 U.S. Open; Credit: Andy Kentla; info via Daily Mail)